Shanxi C&Y Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi C&Y Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Shanghai Fudan Forward S&T Co Ltd
sales of 715.69 million Chinese Renmimbi [US$104.65 million]
of which 59%
Zhejiang Jolly Pharmaceutical Co Ltd
(670.86 million Chinese Renmimbi [US$98.09 million]
of which 82%
was Medicinal), and
Zhejiang Starry Pharmaceutical Co Ltd
(695.18 million Chinese Renmimbi [US$101.65 million]
of which 99%
was Pharmaceuticals Industry).
During the year ended December of 2015, sales at
Shanxi C&Y Pharmaceutical Group Co Ltd were 683.66 million Chinese Renmimbi (US$99.97 million).
increase of 4.6%
versus 2014, when the company's sales were 653.54 million Chinese Renmimbi.
This was the fourth straight year of sales growth at Shanxi C&Y Pharmaceutical Group Co Ltd.